title: Exploiting microRNAs As Cancer Therapeutics.
abstract: miRNAs are a well-studied class of non-coding RNAs, predominantly functioning to down-regulate gene expression from messenger RNA (mRNA) in a targeted manner by binding to complementary sequence on the target mRNA. Many miRNAs have been linked to the development of hallmarks of cancer. miRNAs represent valuable therapeutic targets to exploit in the search for novel cancer treatments, due to their ubiquitous expression and their ability to tightly regulate the gene expression of a whole host of genes and pathways in a single hit. The miRNA system may be harnessed for therapeutic use either through replacement of tumour suppressive miRNAs lost in cancer, or through inhibition of oncogenic miRNAs overexpressed in cancer. There is a large body of work investigating optimal systemic and localised delivery strategies, and while miRNA therapeutics show promise, it is clear that further developments to delivery strategies may be required to allow safe translation of miRNAs to the clinic. The information gleaned from miRNA signatures as biomarkers is already proving invaluable in the fight to better understand and treat individual tumours, and there is great promise to the applications of these small, but mighty molecules in the future of cancer therapeutics.
authors.affiliation: Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
authors.forename: Tamsin
authors.initials: T
authors.lastname: Robb
authors.affiliation: Asbestos Diseases Research Institute (ADRI), Sydney, NSW, 2139, Australia.|Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia.
authors.forename: Glen
authors.initials: G
authors.lastname: Reid
authors.affiliation: Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand. c.blenkiron@auckland.ac.nz.|School of Biological Sciences, The University of Auckland, Auckland, New Zealand. c.blenkiron@auckland.ac.nz.|The University of Auckland, Auckland, New Zealand. c.blenkiron@auckland.ac.nz.
authors.forename: Cherie
authors.identifier: 0000-0002-0217-3808
authors.initials: C
authors.lastname: Blenkiron
mesh_terms: D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D009369:Neoplasms / Q000628:therapy*
chemical_list: D035683:MicroRNAs